Friday, February 10, 2012
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Pharma in Europe
Pharma in Europe
Down the drain: stopping Europe?s innovation migration
For over a century, Europe was the epicentre of pharmaceutical innovation. The last decade, however, has seen the US emerge as the new industry powerhouse, with Europe falling by the wayside. So what went wrong ? and what will it take to make it righ
No Comments
In the frame
The EU has set its sights on becoming the most ?dynamic and competitive knowledge-based economy in the world.?
No Comments
A modern policy for Europe?s pharmaceutical sector
?In 1992, six out of the top 10 medicines were developed in Europe; by 2002, this had fallen to only two.
No Comments
Bridging pharma?s innovation divide
By Paul Rosenberg and Jim Gilbert, Bain & Associates
No Comments
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.